Does the treatment of anxiety in children with ADHD improve outcomes?

Not Applicable

Completed

• Conditions: 1. Attention deficit hyperactivity disorder (ADHD) 2. Anxiety; Mental and Behavioural Disorders

• Registration Number: ISRCTN59518816
• Lead Sponsor: Murdoch Childrens Research Institute (MCRI)

Brief Summary

2019 protocol in https://doi.org/10.1186/s12888-019-2276-3 (added 10/06/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-09-29
• Study Completion: 2019-12-31
• Last Update Posted: 22 June 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 228

Inclusion Criteria

1. Children aged 8 - 12 years
2. Caregiver report of ADHD symptoms meeting Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria for ADHD (child also needs to have been previously diagnosed with ADHD by a paediatrician)
3. Caregiver report of anxiety symptoms meeting Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria for Separation Anxiety Disorder, Generalised Anxiety Disorder, or Social Phobia

Exclusion Criteria

1. Receiving specialised treatment for anxiety from a psychologist or psychiatrist. Participants who are taking medication for anxiety can participate provided they are still experiencing significant anxiety symptoms and have been on stable medication for a minimum of six weeks.
2. Major illness or disability.
3. Non-English speaking

Added 05/10/2016:
4. A score of 15 or greater on the Social Communication Questionnaire, a measure of autism symptoms

Study & Design

• Study Type: Interventional
• Study Design: Not specified